Page last updated: 2024-09-05

tolvaptan and Neoplasms

tolvaptan has been researched along with Neoplasms in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's8 (57.14)24.3611
2020's6 (42.86)2.80

Authors

AuthorsStudies
Huigens, RW; Luesch, H; Norwood, VM; Paciaroni, NG; Ratnayake, R1
Kawada, T1
Anceschi, C; Baldanzi, F; Fibbi, B; Maggi, M; Marroncini, G; Naldi, L; Peri, A1
Jhaveri, KD; Rondon-Berrios, H; Workeneh, BT1
Basal, FB; Bilgetekin, I; Demirci, U; Erturk, I; Karacin, C; Karadurmus, N; Oksuzoglu, B1
Al-Othman, S; Blackhall, F; Brabant, G; Chatzimavridou-Grigoriadou, V; Higham, CE; King, J; Kyriacou, A; Trainer, PJ1
Antonuzzo, A; Berardi, R; Blasi, L; Buosi, R; Lorusso, V; Migliorino, MR; Montesarchio, V; Peri, A; Sabbatini, R; Zilembo, N1
Kitchlu, A; Rosner, MH1
Ali, N; George, M; Lahoti, A; Palla, S; Salahudeen, AK1
Akiyama, T; Aoki, Y; Hosokawa, I; Kato, A; Kawamoto, J; Kuboki, S; Mitsuhashi, N; Miyazaki, M; Nemoto, S; Nishino, H; Ohtsuka, M; Sasaki, K; Satoh, Y; Shimazaki, R; Shimizu, H; Shimizu, Y; Teranaka, R; Ueda, A; Yoichi, T; Yoshitomi, H1
Ahmad, F; Blais, JD; Chiodo, J; Czerwiec, FS; Glaser, LA; Gralla, RJ; Zhou, W1
Villabona, C1
Caimi, G; Urso, C1
Castillo, JJ; Justice, E; Vincent, M1

Reviews

6 review(s) available for tolvaptan and Neoplasms

ArticleYear
Hyponatremia in the cancer patient.
    Kidney international, 2020, Volume: 98, Issue:4

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Humans; Hyponatremia; Inappropriate ADH Syndrome; Neoplasms; Quality of Life; Tolvaptan

2020
Practical issues for the management of hyponatremia in oncology.
    Endocrine, 2018, Volume: 61, Issue:1

    Topics: Antidiuretic Hormone Receptor Antagonists; Disease Management; Humans; Hyponatremia; Inappropriate ADH Syndrome; Neoplasms; Tolvaptan

2018
Hyponatremia in patients with cancer.
    Current opinion in nephrology and hypertension, 2019, Volume: 28, Issue:5

    Topics: Fluid Therapy; Humans; Hyponatremia; Inappropriate ADH Syndrome; Neoplasms; Tolvaptan

2019
[Vasopressin receptor antagonists: the vaptans].
    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2010, Volume: 57 Suppl 2

    Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Benzamides; Benzazepines; Calcium Signaling; Clinical Trials as Topic; Cyclic AMP; Double-Blind Method; Drug Therapy, Combination; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney Tubules, Collecting; Liver Cirrhosis; Morpholines; Multicenter Studies as Topic; Neoplasms; Pituitary Gland, Anterior; Pyrroles; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Second Messenger Systems; Spiro Compounds; Tolvaptan; Vasopressins

2010
[Hyponatremic syndrome].
    La Clinica terapeutica, 2012, Volume: 163, Issue:1

    Topics: Aging; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Brain; Brain Edema; Exercise; Humans; Hyponatremia; Inappropriate ADH Syndrome; Infections; Inflammation; Kidney; Natriuresis; Neoplasms; Osmotic Pressure; Renal Replacement Therapy; Sodium; Tolvaptan; Water Intoxication

2012
Diagnosis and management of hyponatremia in cancer patients.
    The oncologist, 2012, Volume: 17, Issue:6

    Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Disease Management; Humans; Hyponatremia; Hypovolemia; Inappropriate ADH Syndrome; Neoplasms; Receptors, Vasopressin; Risk Factors; Sodium; Tolvaptan

2012

Trials

2 trial(s) available for tolvaptan and Neoplasms

ArticleYear
Tolvaptan in hospitalized cancer patients with hyponatremia: a double-blind, randomized, placebo-controlled clinical trial on efficacy and safety.
    Cancer, 2014, Mar-01, Volume: 120, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Female; Humans; Hyponatremia; Male; Medication Adherence; Middle Aged; Neoplasms; Sodium; Time Factors; Tolvaptan; Treatment Outcome

2014
Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT-1 and SALT-2 trials.
    Cancer medicine, 2017, Volume: 6, Issue:4

    Topics: Administration, Oral; Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Double-Blind Method; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Neoplasms; Sodium; Tolvaptan; Treatment Outcome

2017

Other Studies

6 other study(ies) available for tolvaptan and Neoplasms

ArticleYear
Yohimbine as a Starting Point to Access Diverse Natural Product-Like Agents with Re-programmed Activities against Cancer-Relevant GPCR Targets.
    Bioorganic & medicinal chemistry, 2020, 07-15, Volume: 28, Issue:14

    Topics: Antineoplastic Agents; Biological Products; Dose-Response Relationship, Drug; Humans; Molecular Structure; Molecular Targeted Therapy; Neoplasms; Receptors, G-Protein-Coupled; Structure-Activity Relationship; Yohimbine

2020
Survival analysis in cancer patients with hyponatremia: effectiveness of tolvaptan treatment.
    International urology and nephrology, 2022, Volume: 54, Issue:10

    Topics: Antidiuretic Hormone Receptor Antagonists; Humans; Hyponatremia; Neoplasms; Survival Analysis; Tolvaptan; Treatment Outcome

2022
The V
    Journal of endocrinological investigation, 2022, Volume: 45, Issue:9

    Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cell Proliferation; Humans; Hyponatremia; Neoplasms; rho-Associated Kinases; Sodium; Tolvaptan

2022
Tolvaptan treatment in hyponatremia due to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): effects on survival in patients with cancer.
    International urology and nephrology, 2021, Volume: 53, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Female; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Neoplasms; Retrospective Studies; Survival Rate; Tolvaptan

2021
Clinical Experience of the Efficacy and Safety of Low-dose Tolvaptan Therapy in a UK Tertiary Oncology Setting.
    The Journal of clinical endocrinology and metabolism, 2021, 10-21, Volume: 106, Issue:11

    Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Female; Follow-Up Studies; Humans; Hyponatremia; Male; Neoplasms; Prognosis; Retrospective Studies; Tolvaptan

2021
[Effect of tolvaptan on ascites due to malignancy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2015, Volume: 42, Issue:2

    Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Ascites; Benzazepines; Female; Humans; Male; Middle Aged; Neoplasms; Tolvaptan

2015